News Releases

DALLAS, Sept. 28, 2023 – Spectral MD, Inc. (“SMD”), a subsidiary of Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced it has

DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) --  Spectral  AI, Inc.  (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”),  an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced today that the Company will

Company Renamed “Spectral AI, Ltd.” and Will Commence Trading on Nasdaq Global Market Under the Symbol “MDAI” Effective September 12, 2023 Overview: Spectral AI is the Only Publicly Listed, AI-Driven Predictive Medical Diagnostic Company Developing Technology that is Specifically Engineered to

The following amendment has been made to the ' Rosecliff Stockholders Approve Business Combination with Spectral MD at Special Meeting' announcement released on 7 September 2023 at 11:36 under RNS No 7453L. Expected time and date of the Closing of the Transaction confirmed as 5:00 'p.m.' EST All

Rosecliff Stockholders Approve Business Combination with Spectral MD at Special Meeting LONDON, U.K. AND DALLAS, TX, U.S. -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care,

Spectral MD Moves One Step Closer to Completion of Business Combination with Result of General Meeting LONDON, U.K. AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions

LONDON, U.K. AND DALLAS, TX, U.S. -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces the exercise of options (the "Exercise") by certain employees of the

Form S-4 approved by the U.S. Securities and Exchange Commission and now effective Spectral MD posting circular ahead of a general meeting to approve business combination with Rosecliff   LONDON, U.K. AND DALLAS, TX, U.S . -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI)

  LONDON, U.K. AND DALLAS, TX, U.S.  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces that it has released a short investor video further to the  recent update

Rosecliff to hold special meeting to approve the Transaction on September 6, 2023 LONDON, U.K. AND DALLAS, TX, U.S.  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes